Michelle Mello

Michelle Mello Stanford

Michelle Mello, JD, PhD

  • Professor, Health Policy
  • Professor, Law
(650) 725-3894 (voice)

Biography

Michelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine.  She conducts empirical research into issues at the intersection of law, ethics, and health policy.  She is the author of more than 230 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, health information privacy, and other topics.
 
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40.  From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
 
Dr. Mello teaches courses in torts, public health law, and health policy.  She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. 

In The News

Chip Kahn and Michelle Mello for KFF podcast
Q&As

Podcast: Guardrails for AI in Health Care—How High?

AI is racing into everyday medicine, yet the rules of the road are still being written. SHP's Michelle Mello joins this KFF podcast to discuss.
Podcast: Guardrails for AI in Health Care—How High?
Illustration for Michelle Mello Q&A in The Regulatory Review
Q&As

How Regulations Shape and Constrain Medical Practice

Stanford Health Policy's Michelle Mello discusses how the law, artificial intelligence, and the COVID-19 pandemic have shaped health care in this Q&A with The Regulatory Review.
How Regulations Shape and Constrain Medical Practice
Illustration of AI in health care
Q&As

Exploring Liability Risks of Using AI Tools in Patient Care

Research led by SHP’s Michelle Mello provides some clarity regarding liability over AI technologies that are rapidly being introduced to health care. She and her co-author analyzed more than 800 tort cases involving both AI and conventional software in health care and non-health-care contexts to see how decisions related to AI and liability might play out in the courts.
Exploring Liability Risks of Using AI Tools in Patient Care